A once nearly eradicated disease surges back, now more dangerous: antibiotic resistance. Typhoid fever, caused by Salmonella enterica serotype Typhi (S. Typhi), evolves quickly, growing harder to treat—threatening a global public health crisis.

Silent Evolution of an Ancient Disease

Modern medicine had sidelined typhoid fever for decades. Yet new research shows its return with enhanced evasion of traditional treatments. A The Lancet Microbe study reveals S. Typhi alarming resistance to antibiotics—including last-line drugs—complicating eradication.​

The study examined 3,489 bacterial samples from 2014-2019 in South Asia (India, Pakistan, Nepal, Bangladesh). Findings: many strains resist first-line antibiotics (ampicillin, chloramphenicol, trimethoprim/sulfamethoxazole) plus fluoroquinolones and third-generation cephalosporins—key for severe infections.​

Most alarming: resistant strains emerge/replace less dangerous ones rapidly. Stanford’s Jason Andrews, infectious disease expert and coauthor, warns: “The speed of highly resistant S. Typhi emergence/spread in recent years truly concerns.” This bacterium adapts, defying extinction.

Threat from Asia Spreading Worldwide

Though South Asia epicenter, resistant typhoid no longer regional. Since 1990, ~200 international transmission cases of extremely drug-resistant (XDR) strains hit Southeast Asia, East/Southern Africa, UK, Canada, USA.

Epidemiologists’ fears confirmed: resistant typhoid crosses borders, now global risk. Travel, tourism, migration spread mutated strains; weak public health systems hinder containment.

Study’s dire note: last defense azithromycin loses efficacy via detected mutations—edging toward no effective oral treatments. Untreated, typhoid kills 1 in 5; impact devastates resource-poor areas.​

Over 11 million cases yearly, mostly in poverty with poor care access. Continued resistance risks uncontrollable outbreaks, high mortality—even in once-typhoid-free nations.​

Vaccination: Best Hope Against Unstoppable Resistance

With therapies dwindling, experts unite on solution: expand/accelerate typhoid vaccination. Conjugate vaccines effectively cut incidence, curb resistant strains.

Pakistan pioneered, first nationally systematic typhoid vaccination—promising results may inspire high-prevalence nations.

India study: vaccinating urban high-risk children prevents up to 36% cases/deaths. Cuts disease burden, limits new resistant mutations.

Experts stress: vaccines can’t limit to affected countries. S. Typhi‘s global spread demands universal immunization access. Report: “Essential where resistance high, but not exclusive there.”

Typhoid—far from past relic—emerges as 21st-century top infectious threat. Growing resistance to all known oral antibiotics demands immediate action. Vaccination stands as sole effective counter to bacteria outsmarting modern medicine. Question: will we act in time?

Reference:

• The Lancet Microbe/The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study. Link

Esta entrada también está disponible en: Español